Vanguard Group Inc Ionis Pharmaceuticals Inc Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 16,714,846 shares of IONS stock, worth $688 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,714,846
Previous 16,383,934
2.02%
Holding current value
$688 Million
Previous $494 Million
33.6%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding IONS
# of Institutions
413Shares Held
149MCall Options Held
1.73MPut Options Held
729K-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$661 Million0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$516 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$425 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$323 Million7.06% of portfolio
-
Wellington Management Group LLP Boston, MA6.35MShares$261 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.85B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...